EUVIMEDEUVIMED entdecken
KommentarOpen Access · CC BY 4.0

Slicing through the challenge of maintaining Pneumocystis in the laboratory

Olga A Nev iD, Lucian Duvenage, Alistair J P Brown iD, Rachael Dangarembizi, Jennifer Claire Hoving

mBio · 2024

DOI: 10.1128/mbio.03277-23 ↗

Kurz gefasst

Kommentar in der Zeitschrift mBio, 2024. Verfasst von Olga A Nev und 4 weiteren Autor:innen. Beteiligte Einrichtung: Biosciences and Living Systems Institute, University of Exeter, Exeter, United Kingdom. Hauptthemen laut MEDLINE: Pneumonia, Pneumocystis, Pneumocystis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Medical Research Council, UKRI | Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pneumocystis jirovecii is a major fungal pathogen of humans that causes life-threatening lung infections in immunocompromised individuals. Despite its huge global impact upon human health, our understanding of the pathobiology of this deadly fungus remains extremely limited, largely because it is not yet possible to cultivate Pneumocystis in vitro, independently of the host. However, a recent paper by Munyonho et al. offers a major step forward (F. T. Munyonho, R. D. Clark, D. Lin, M. S. Khatun, et al., 2023, mBio 15:e01464-23, https://doi.org/10.1128/mbio.01464-23 ). They show that it is possible to maintain both the trophozoite and cyst forms of the mouse pathogen, Pneumocystis murina, in precision-cut lung slices for several weeks. Furthermore, they demonstrate that this offers the exciting opportunity to examine potential virulence factors such as possible biofilm formation as well as antifungal drug responses in the lung.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pneumonia, PneumocystisPneumocystisHumansAnimalsMiceAntifungal AgentsLung

Stichwörter der Autor:innen

Pneumocystisfungal pathogenicitymedical mycologyprecision-cut lung slices

Substanzen

Antifungal Agents

Autor:innen und Institutionen

  • Biosciences and Living Systems Institute, University of Exeter, Exeter, United Kingdom.
  • Medical Research Council Centre for Medical Mycology, University of Exeter, Exeter, United Kingdom.
  • CMM AFRICA Medical Mycology Research Unit, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
  • Department of Pathology, Division of Immunology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
  • Department of Human Biology, Division of Physiological Sciences, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
  • Neuroscience Institute, Faculty of Health Sciences, University of Cape Town, Groote Schuur Hospital, Cape Town, South Africa.

ORCID-Profile: Olga A Nev, Alistair J P Brown

Förderung

  • Wellcome Trust
  • Medical Research Council
  • UKRI | Medical Research Council
  • Carnegie Corporation of New York
  • UK Research and Innovation

Zitieren

APA

Nev, O. A., Duvenage, L., Brown, A. J. P., Dangarembizi, R., & Hoving, J. C. (2024). Slicing through the challenge of maintaining Pneumocystis in the laboratory. mBio. https://doi.org/10.1128/mbio.03277-23

Vancouver

Nev OA, Duvenage L, Brown AJP, Dangarembizi R, Hoving JC. Slicing through the challenge of maintaining Pneumocystis in the laboratory. mBio. 2024. doi:10.1128/mbio.03277-23

BibTeX
@article{Nev2024,
  author = {Nev, Olga A and Duvenage, Lucian and Brown, Alistair J P and Dangarembizi, Rachael and Hoving, Jennifer Claire},
  title = {Slicing through the challenge of maintaining Pneumocystis in the laboratory},
  journal = {mBio},
  year = {2024},
  doi = {10.1128/mbio.03277-23}
}
Kostenlos starten →